PL377520A1 - Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń - Google Patents

Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń

Info

Publication number: PL377520A1
Authority: PL; Poland
Prior art keywords: fibromyalgia; disorders; treatment; pregabalin derivatives; pregabalin
Prior art date: 2002-12-13

Application number

PL377520A

Other languages

English (en)

Inventor

David James Dooley

Charles Price Taylor Jr.

Andrew John Thorpe

David Juergen Wustrow

Original Assignee

Warner-Lambert Company Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-12-13

Filing date

2003-12-03

Publication date

2006-02-06

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=32600153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL377520(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2003-12-03 Application filed by Warner-Lambert Company Llc filed Critical Warner-Lambert Company Llc

2006-02-06 Publication of PL377520A1 publication Critical patent/PL377520A1/pl

Links

208000001640 Fibromyalgia Diseases 0.000 title 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
208000035475 disorder Diseases 0.000 title 1
AYXYPKUFHZROOJ-ZETCQYMHSA-N pregabalin Chemical class CC(C)C[C@H](CN)CC(O)=O AYXYPKUFHZROOJ-ZETCQYMHSA-N 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/14—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Immunology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Transplantation (AREA)
Anesthesiology (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Otolaryngology (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

PL377520A 2002-12-13 2003-12-03 Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń PL377520A1 (pl)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US43349102P	2002-12-13	2002-12-13
US48774003P	2003-07-16	2003-07-16

Publications (1)

Publication Number	Publication Date
PL377520A1 true PL377520A1 (pl)	2006-02-06

Family

ID=32600153

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL377520A PL377520A1 (pl)	2002-12-13	2003-12-03	Pochodne pregabaliny przeznaczone do leczenia fibromialgii i innych zaburzeń

Country Status (15)

Country	Link
US (1)	US20090203782A1 (pl)
EP (2)	EP2172197A1 (pl)
JP (1)	JP2006513257A (pl)
KR (1)	KR20050085636A (pl)
CN (1)	CN101862317A (pl)
AU (1)	AU2003303040B2 (pl)
BR (1)	BR0317253A (pl)
CA (1)	CA2505788A1 (pl)
MX (1)	MXPA05006320A (pl)
NO (1)	NO20052264L (pl)
NZ (1)	NZ540591A (pl)
PL (1)	PL377520A1 (pl)
RU (2)	RU2353358C2 (pl)
TW (1)	TW200423925A (pl)
WO (1)	WO2004054566A1 (pl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
MXPA05010515A (es) *	2003-03-31	2006-03-10	Xenoport Inc	Tratamiento o prevencion de sofocos calientes utilizando profarmacos de analogos de gaba.
WO2005025563A1 (en) *	2003-09-12	2005-03-24	Warner-Lambert Company Llc	Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders
US20070141684A1 (en)	2005-12-21	2007-06-21	Pfizer Inc	Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
EP3102195B1 (en)	2014-02-03	2021-10-06	Quadriga Biosciences, Inc.	Beta-substituted beta-amino acids and analogs as chemotherapeutic agents
EP3102194A1 (en)	2014-02-03	2016-12-14	Quadriga Biosciences, Inc.	Beta-substituted gamma-amino acids and analogs as chemotherapeutic agents
AR105592A1 (es)	2015-08-03	2017-10-18	Quadriga Biosciences Inc	b-AMINOÁCIDOS b-SUSTITUIDOS Y ANÁLOGOS COMO AGENTES QUIMIOTERAPÉUTICOS Y USOS DE LOS MISMOS
CN115739134B (zh) *	2022-11-24	2024-08-02	贵州大学	一种利用三氯化钌废弃物制备氯乙烯合成用复合催化剂的方法

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4087544A (en)	1974-12-21	1978-05-02	Warner-Lambert Company	Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de)	1974-12-21	1982-09-23	Gödecke AG, 1000 Berlin	1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
DK0641330T3 (da)	1992-05-20	2001-12-03	Univ Northwestern	Gaba- og L-glutaminsyreanaloger til antikrampeanfaldsbehandling
TW336932B (en)	1992-12-17	1998-07-21	Pfizer	Amino-substituted pyrazoles
DK0674624T3 (da)	1992-12-17	1999-09-13	Pfizer	Pyrazoler med CRF-antagonistisk aktivitet
TW370529B (en)	1992-12-17	1999-09-21	Pfizer	Pyrazolopyrimidines
KR100190730B1 (ko)	1992-12-17	1999-06-01	디. 제이. 우드, 스피겔 알렌 제이	부신피질 호르몬 유리인자(crf) 길항물질로서 치환된 피라졸
BR9307646A (pt)	1992-12-17	1999-05-25	Pfizer	Pirrolopirimidinas como antagonistas de crf
US5670539A (en) *	1993-07-21	1997-09-23	New York State Office Of Mental Health	Treatment of movement disorders using large neutral amino acids
US6372792B1 (en) *	1996-04-26	2002-04-16	Guy Chouinard	Method for treating anxiety, anxiety disorders and insomnia
EP0934061B3 (en) *	1996-07-24	2015-01-21	Warner-Lambert Company LLC	Isobutylgaba and its derivatives for the treatment of pain
SE9603408D0 (sv) *	1996-09-18	1996-09-18	Astra Ab	Medical use
NZ334898A (en)	1996-10-23	2000-09-29	Warner Lambert Co	Substituted gamma aminobutyric acids as pharamceutical agents
US6127418A (en) *	1997-08-20	2000-10-03	Warner-Lambert Company	GABA analogs to prevent and treat gastrointestinal damage
ATE323067T1 (de)	1997-10-27	2006-04-15	Warner Lambert Co	Zyklische aminosäuren und deren derivate als arzneimittel
BR9911887A (pt)	1998-07-09	2001-03-27	Warner Lambert Co	Método para o tratamento da insÈnia
US6248363B1 (en) *	1999-11-23	2001-06-19	Lipocine, Inc.	Solid carriers for improved delivery of active ingredients in pharmaceutical compositions
AU4334900A (en) *	1999-04-09	2000-11-14	Euro-Celtique S.A.	Sodium channel blocker compositions and the use thereof
US7164034B2 (en) *	1999-06-10	2007-01-16	Pfizer Inc.	Alpha2delta ligands for fibromyalgia and other disorders
US6642398B2 (en) *	1999-06-10	2003-11-04	Warner-Lambert Company	Mono-and disubstituted 3-propyl gamma-aminobutyric acids
CZ300834B6 (cs) *	1999-06-10	2009-08-19	Warner-Lambert Company Llc	Mono- a disubstituované kyseliny 3-propyl-gamma-aminomáselné
US6309663B1 (en) *	1999-08-17	2001-10-30	Lipocine Inc.	Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
PT1202725E (pt) *	1999-07-22	2007-07-11	Universuty Of Rochester	Método para tratar sintomas de alteração hormonal, incluindo afrontamentos.
US6281207B1 (en) *	1999-09-15	2001-08-28	Reed Richter	Treatment of movement disorders by administration of mirtazapine
HN2000000224A (es)	1999-10-20	2001-04-11	Warner Lambert Co	Aminoacidos biciclicos como agentes farmaceuticos
GB2362646A (en)	2000-05-26	2001-11-28	Warner Lambert Co	Cyclic amino acid derivatives useful as pharmaceutical agents
GB2365425A (en) *	2000-08-01	2002-02-20	Parke Davis & Co Ltd	Alkyl amino acid derivatives useful as pharmaceutical agents
US20020099013A1 (en) *	2000-11-14	2002-07-25	Thomas Piccariello	Active agent delivery systems and methods for protecting and administering active agents
IL145584A0 (en) *	2000-10-02	2002-06-30	Pfizer Prod Inc	Nmda nr2b antagonists for treatment
WO2002069974A1 (en) *	2001-03-05	2002-09-12	Andrew Holman	Administration of sleep restorative agents
ES2265040T3 (es) *	2001-05-25	2007-02-01	Warner-Lambert Company Llc	Composicion farmaceutica liquida.

2003
- 2003-12-03 EP EP09175270A patent/EP2172197A1/en not_active Withdrawn
- 2003-12-03 JP JP2005502471A patent/JP2006513257A/ja active Pending
- 2003-12-03 MX MXPA05006320A patent/MXPA05006320A/es active IP Right Grant
- 2003-12-03 NZ NZ540591A patent/NZ540591A/en unknown
- 2003-12-03 BR BR0317253-8A patent/BR0317253A/pt not_active IP Right Cessation
- 2003-12-03 KR KR1020057010833A patent/KR20050085636A/ko not_active Ceased
- 2003-12-03 AU AU2003303040A patent/AU2003303040B2/en not_active Ceased
- 2003-12-03 EP EP03813230A patent/EP1572188A1/en not_active Withdrawn
- 2003-12-03 RU RU2005118081/14A patent/RU2353358C2/ru not_active IP Right Cessation
- 2003-12-03 WO PCT/IB2003/005712 patent/WO2004054566A1/en not_active Ceased
- 2003-12-03 CA CA002505788A patent/CA2505788A1/en not_active Abandoned
- 2003-12-03 PL PL377520A patent/PL377520A1/pl not_active Application Discontinuation
- 2003-12-03 CN CN201010165706A patent/CN101862317A/zh active Pending
- 2003-12-12 TW TW092135197A patent/TW200423925A/zh unknown
2005
- 2005-05-10 NO NO20052264A patent/NO20052264L/no not_active Application Discontinuation
2008
- 2008-10-13 RU RU2008140653/15A patent/RU2008140653A/ru unknown
2009
- 2009-04-20 US US12/426,501 patent/US20090203782A1/en not_active Abandoned

Also Published As

Publication number	Publication date
BR0317253A (pt)	2005-11-01
NZ540591A (en)	2008-03-28
RU2353358C2 (ru)	2009-04-27
NO20052264D0 (no)	2005-05-10
KR20050085636A (ko)	2005-08-29
CA2505788A1 (en)	2004-07-01
JP2006513257A (ja)	2006-04-20
MXPA05006320A (es)	2005-08-26
EP1572188A1 (en)	2005-09-14
RU2005118081A (ru)	2006-01-20
RU2008140653A (ru)	2010-04-20
TW200423925A (en)	2004-11-16
NO20052264L (no)	2005-09-12
EP2172197A1 (en)	2010-04-07
AU2003303040A1 (en)	2004-07-09
CN101862317A (zh)	2010-10-20
WO2004054566A1 (en)	2004-07-01
AU2003303040B2 (en)	2009-04-23
US20090203782A1 (en)	2009-08-13

Legal Events

Date	Code	Title	Description
2011-03-31	REFS	Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)

Publication	Publication Date	Title
ZA200504724B (en)	2009-01-28	Pregabalin derivatives for the treatment of fibromyalgia and other disorders
AU2003286567A8 (en)	2004-05-13	Methods for the treatment of skin disorders
AU2003233583A1 (en)	2003-12-12	Oral lactoferrin in the treatment of respiratory disorders
IL208191A0 (en)	2010-12-30	Compositions and methods for treating rage-associated disorders
EP1509279A4 (en)	2009-10-28	DEVICE AND METHOD FOR THE TREATMENT OF HEART DISEASES
IL210090A0 (en)	2011-07-31	TREATMENT OF TNFa RELATED DISORDERS
IL165820A0 (en)	2006-01-15	Diphenylazetidinone derivatives for treating disorders of the lipid metabolism
AU2003213787A1 (en)	2003-09-22	Compositions and methods for the treatment of anorectal disorders
HRP20040906B1 (en)	2013-01-31	Bisphosphonic acid for the treatment and prevention of ostreoporosis
AU2003228819A8 (en)	2003-11-17	Combinations for the treatment of inflammatory skin disorders
EP1567198A4 (en)	2006-05-31	MATERIALS AND METHOD FOR THE TREATMENT OF EYE DISEASES
EP1478438A4 (en)	2007-11-14	TECHNIQUES AND COMPOSITIONS FOR THE TREATMENT OF ASTHMA AND RELATED DISORDERS
PL377662A1 (pl)	2006-02-06	Pregabalina i jej pochodne w leczeniu fibromialgii i innych zaburzeń pokrewnych
AU2003270536A1 (en)	2004-04-30	Method of treating skin disorders
AU2002363935A1 (en)	2003-07-30	Composition and method for the treatment of anorectal disorders
IL162818A0 (en)	2005-11-20	Combination therapy for the treatment of bacterialinfections
GB0128674D0 (en)	2002-01-23	Treatment of sleep disorders and the like
AU2003297612A8 (en)	2004-06-23	2-substituted-3-propenamide derivatives and methods of using the same
EP1539100A4 (en)	2006-01-18	COMPOSITIONS AND METHODS FOR THE TREATMENT OF SKIN DISORDERS
PL377286A1 (pl)	2006-01-23	Analogi gabapentyny do włókniako-mięśniakowych i innych pokrewnych zaburzeń
SI1553967T1 (sl)	2011-07-29	Uporaba amid derivata GE 2270 faktorja A3 za zdravljenje aken
HRP20041160A2 (en)	2005-08-31	Novel combination for the treatment of airway disorders
NO20052264D0 (no)	2005-05-10	Pregahalinderivater for behandling av fibromyalgi og andre forstyrrelser
GB2410693B (en)	2007-08-01	Method of ameliorating vision-inhibiting effects of cataracts and the like
GB0201025D0 (en)	2002-03-06	The treatment of degenerative diseases